Dr KADISON MICHEL1,2, Mr MOHANDEEP (JIMMY) SODHI1,4, Dr SHERAZ JAMIL1, Dr USMAN MAHMOOD3, Dr ANIL XAVIER1, Dr UBAIDULLAH DAWOOD1
1Goulburn Valley Health, Shepparton, Australia, 2The University of Melbourne, Shepparton, Australia, 3Northern Hospital, Epping, Australia, 4Monash University, Melbourne, Australia
Biography:
Dr Kadison Anthony Michel is a nephrology registrar and College of Intensive Care Medicine trainee at Goulburn Valley Health in Shepparton, Victoria. He holds a Bachelor of Biomedical Science from Monash University and a Doctor of Medicine from the University of Melbourne. Kadison tutors medical students through the Rural Clinical School and coordinates regional ICU skills workshops. His research interests include renal pathology, audit‑driven quality improvement and equitable access to specialist care in rural settings. Outside medicine he enjoys camping, classic literature, building Lego and exploring advances in artificial intelligence.
Aim:
To evaluate the diagnostic yield and safety of native kidney biopsy at a regional Australian centre.
Background:
Evidence from regional services is limited; most data derive from metropolitan “renal hubs”.
Methods:
We audited adult native kidney biopsies performed at Goulburn Valley Health, Shepparton, between 9 February 2021 and 25 February 2025. Demographic, clinical, histopathological and complication data were extracted retrospectively.
Results:
Fifty-three biopsies were analysed: mean age 60 ± 17 years, 60 % male. Indications were nephrotic‑range proteinuria (29/53, 55 %), acute kidney injury (26/53, 49 %) and haematuria with proteinuria (24/53, 45 %). Tissue adequacy was 94 %. A specific diagnosis was obtained in 42/53 (79 %), 3/53 (6 %) showed chronic nonspecific change, 8/53 (15 %) were nondiagnostic. Major pathologies were hypertensive nephrosclerosis (9/53, 17 %), diabetic nephropathy (8/53, 15 %), acute interstitial nephritis (6/53, 11 %), focal segmental glomerulosclerosis (4/53, 8 %), minimal change disease (4/53, 8 %) and IgA nephropathy (3/53, 6 %). No procedure-related complications occurred (0 %; 95 % CI 0–6.8 %); 39/53 (74 %) were managed as day cases.
Conclusions:
Native kidney biopsy delivered high diagnostic yield and zero observed complications in this non-hub regional service, matching metropolitan benchmarks, and supporting continued local provision of the procedure.